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Gonadotropin-releasing hormone (GnRH) neurons are controlled by 17β-estradiol (E2)
contributing to the steroid feedback regulation of the reproductive axis. In rodents, E2
exerts a negative feedback effect upon GnRH neurons throughout the estrus-diestrus
phase of the ovarian cycle. The present study was undertaken to reveal the role
of estrogen receptor subtypes in the mediation of the E2 signal and elucidate the
downstream molecular machinery of suppression. The effect of E2 administration
at low physiological concentration (10 pM) on GnRH neurons in acute brain slices
obtained from metestrous GnRH-green fluorescent protein (GFP) mice was studied
under paradigms of blocking or activating estrogen receptor subtypes and interfering
with retrograde 2-arachidonoylglycerol (2-AG) signaling. Whole-cell patch clamp
recordings revealed that E2 significantly diminished the frequency of spontaneous
postsynaptic currents (sPSCs) in GnRH neurons (49.62 ± 7.6%) which effect was
abolished by application of the estrogen receptor (ER) α/β blocker Faslodex (1 µM).
Pretreatment of the brain slices with cannabinoid receptor type 1 (CB1) inverse
agonist AM251 (1 µM) and intracellularly applied endocannabinoid synthesis blocker
THL (10 µM) significantly attenuated the effect of E2 on the sPSCs. E2 remained
effective in the presence of tetrodotoxin (TTX) indicating a direct action of E2 on
GnRH cells. The ERβ specific agonist DPN (10 pM) also significantly decreased the
frequency of miniature postsynaptic currents (mPSCs) in GnRH neurons. In addition,
the suppressive effect of E2 was completely blocked by the selective ERβ antagonist
PHTPP (1 µM) indicating that ERβ is required for the observed rapid effect of
the E2. In contrast, the ERα agonist PPT (10 pM) or the membrane-associated
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G protein-coupled estrogen receptor (GPR30) agonist G1 (10 pM) had no significant
effect on the frequency of mPSCs in these neurons. AM251 and tetrahydrolipstatin (THL)
significantly abolished the effect of E2 whereas AM251 eliminated the action of DPN on
the mPSCs. These data suggest the involvement of the retrograde endocannabinoid
mechanism in the rapid direct effect of E2. These results collectively indicate that
estrogen receptor beta and 2-AG/CB1 signaling mechanisms are coupled and play an
important role in the mediation of the negative estradiol feedback on GnRH neurons in
acute slice preparation obtained from intact, metestrous mice.
Keywords: GnRH neuron, negative estrogen feedback, estrogen receptor beta, GABA, 2-AG, retrograde signaling,
CB1
INTRODUCTION
Hypothalamic gonadotropin-releasing hormone (GnRH)
neurons are key regulators of reproduction (Cattanach et al.,
1977). They release GnRH into the portal circulation whereby
stimulate gonadotropin synthesis and gonadal hormone
production (Herbison, 1998). In female rodents, 17β-estradiol
(E2) is a main regulator of GnRH neuronal functions (Herbison,
1998). E2 is known to modulate GnRH output via positive
and negative feedback mechanisms (Ojeda et al., 1975; Nakai
et al., 1978; Attardi et al., 1980; Radovick et al., 2012) and these
effects are mediated by estrogen receptors (ERs). GnRH neurons
express exclusively estrogen receptor beta (Hrabovszky et al.,
2001, 2007; Kalló et al., 2001). The other, alpha subtype of
classical estrogen receptor also plays an important role in steroid
feedback effects to GnRH neurons, however, this receptor
subtype was found exclusively in various synaptic afferent
systems, but not in GnRH neurons (Couse and Korach, 1999;
Simonian et al., 1999; Wersinger et al., 1999; Couse et al., 2003;
Cheong et al., 2014; Yeo and Herbison, 2014; Dubois et al.,
2015).
Both ERα and β as transcription factors are located mainly
in the nuclei of various hypothalamic neurons where activation
of them by E2 triggers classical genomic actions regulating
gene transcription (Marino et al., 2006; Radovick et al.,
2012). Nevertheless, E2 also exerts rapid, non-genomic actions
activating intracellular signaling pathways through extranuclear
ERα, ERβ, and G protein-coupled estrogen receptor (GPR30;
Abe et al., 2008; Kelly and Rønnekleiv, 2012; Radovick
et al., 2012; Kwakowsky et al., 2014). This rapid action of
estradiol on GnRH neurons also effectively modulates their
functions. E2 administration at low physiological concentration
has been published to suppress the firing rate of GnRH
neurons with involvement of fast neurotransmission (Chu
et al., 2009). The main regulatory neurotransmitter to GnRH
neurons is γ-aminobutyric acid (GABA) which is also an
important player in the steroid feedback control of GnRH
neurons (Sullivan and Moenter, 2003; Moenter and DeFazio,
2005; Christian and Moenter, 2007; Chen and Moenter, 2009;
Penatti et al., 2010; Watanabe et al., 2014). GABAergic
input received by GnRH neurons is excitatory due to the
elevated intracellular chloride level in these cells (DeFazio
et al., 2002; Yin et al., 2008; Herbison and Moenter, 2011;
Watanabe et al., 2014; Taylor-Burds et al., 2015). Thus, it
was also plausible to suppose the involvement of GABA
in the suppression of firing of GnRH neurons upon E2
administration (Chu et al., 2009). Nevertheless, activity of
GABAergic afferents reaching GnRH neurons can be modulated
by the retrograde endocannabinoid signaling mechanisms
regulating GABA release from cannabinoid receptor type 1 (CB1)
containing axon terminals (Farkas et al., 2010).
In the present study, we hypothesized that the suppressing
effect of E2 applied at low physiological concentration on
GnRH neurons requires the activation of ERβ and retrograde
endocannabinoid signaling mechanisms resulting in the
repression of GABAergic neurotransmission onto these neurons.
To test this hypothesis, a series of electrophysiological studies
has been carried out in GnRH-green fluorescent protein (GFP)
neurons of acute slices obtained from intact, metestrous female
mice.
MATERIALS AND METHODS
Ethics Statement
All studies were carried out with permissions from the Animal
Welfare Committee of the Institute of Experimental Medicine
(IEM) Hungarian Academy of Sciences (Permission Number:
A5769-01) and in accordance with legal requirements of
the European Community (Decree86/609/EEC). All animal
experimentation described was conducted in accord with
accepted standards of humane animal care and all efforts were
made to minimize suffering.
Experimental Animals
Adult, gonadally intact GnRH-GFP transgenic female mice with
C57BL/6J genetic background were used for electrophysiological
experiments. In this animal model, a GnRH promoter segment
drives selective GFP expression in the majority of GnRH neurons
(Suter et al., 2000). Phase of the estrous cycle was checked by
both evaluating vaginal smears (Nelson et al., 1982; Caligioni,
2009; Byers et al., 2012) and visual observation of the vaginal
opening using the method elaborated recently (Caligioni, 2009;
Byers et al., 2012). Mice were used from local colonies bred
at the Medical Gene Technology Unit of the IEM. They were
maintained in 12 h light/dark cycle (lights on at 06:00 h) and
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temperature controlled environment (22 ± 2◦C), with standard
rodent chow and tap water available ad libitum. All mice
were housed in the same room under same environmental
conditions.
Brain Slice Preparation and Recording
Metestrous mice were deeply anesthetized by Isoflurane
inhalation. All mice were killed between 9 a.m. and 10 a.m. and
all recordings performed between 1 p.m. and 3 p.m. time. After
decapitation, brain was removed rapidly and immersed in ice-
cold cutting solution, which had been extensively bubbled with
a mixture of 95% O2 and 5% CO2. The solution contained the
following (in mM): saccharose 205, KCl 2.5, NaHCO3 26, MgCl2
5, NaH2PO4 1.25, CaCl2 1, and glucose 10. Forebrain blocks
were dissected and 250 µm-thick coronal slices were prepared
from the medial septum/preoptic area (POA) with a VT-1000S
Vibratome (Leica GmBH, Wetzlar, Germany) and placed in
the ice-cold oxygenated cutting solution. The slices containing
POA were transferred into artificial cerebrospinal fluid (aCSF,
in mM: NaCl 130, KCl 3.5, NaH2PO4 1.25, MgSO4 1.2, CaCl2
2.5, NaHCO3 26, glucose 10) saturated with O2/CO2 and kept
in it for 1 h to equilibrate. Equilibration started at 33◦C and
was allowed to cool to room temperature. Electrophysiological
recordings were carried out at 33◦C, during which the brain slices
were oxygenated by bubbling the aCSF with O2/CO2. Axopatch
200B patch clamp amplifier, Digidata-1322A data acquisition
system, and pCLAMP 10.4 software (Molecular Devices Co.,
Sunnyvale, CA, USA) were used for recording. Cells were
visualized with a BX51WI IR-DIC microscope (Olympus Co.,
Tokyo, Japan) located on an anti-vibration table (Supertech
Kft, Pécs, Hungary). The patch electrodes (OD = 1.5 mm,
thin wall; Hilgenberg GmbH, Malsfeld, Germany) were pulled
with a Flaming-Brown P-97 puller (Sutter Instrument Co.,
Novato, CA, USA) and polished with an MF-830 microforge
(Narishige, Tokyo, Japan). GnRH-GFP neurons were identified
by brief illumination at 470 nm using an epifluorescent filter
set, based on their green fluorescence, typical fusiform shape,
and topographic location in the POA (Suter et al., 2000).
After control recording (5 min), the slices were treated with
various drugs and the recording continued for a subsequent
10 min.
Loose-Patch Experiments
Recording of action current firing of GnRH neurons was carried
out at 33◦C. Pipette potential was 0 mV, pipette resistance
1–2MΩ, and resistance of loose-patch seal 7–40MΩ. The pipette
solution contained (inmM): NaCl 150, KCl 3.5, CaCl2 2.5, MgCl2
1.3, HEPES 10, and glucose 10 (pH 7.3).
After recording basal action currents, the E2 (10 pM; Sigma)
was added in a single bolus to the brain slice in the recording
chamber, and the recording continued for a subsequent 10 min.
Whole-Cell Patch Clamp Experiments
The cells were voltage clamped at −70 mV holding potential.
Pipette offset potential, series resistance (Rs) and capacitance
were compensated before recording. Only cells with low
holding current (<50 pA) and stable baseline were used.
Input resistance (Rin), Rs, and membrane capacity (Cm)
were also measured before each recording by using 5 mV
hyperpolarizing pulses. To ensure consistent recording qualities,
only cells with Rs < 20 MΩ, Rin > 500 MΩ, and Cm > 10 pF
were accepted. The intracellular pipette solution contained
(in mM): HEPES 10, KCl 140, EGTA 5, CaCl2 0.1, Mg-
ATP 4, and Na-GTP 0.4 (pH 7.3). The resistance of the
patch electrodes was 2–3 MΩ. The spontaneous postsynaptic
currents (sPSCs) measurements were carried out with an
initial control recording (5 min), then low physiological
dose of E2 (10pM; Nelson et al., 1992; Christian et al., 2005;
Freeman, 2006; Chu et al., 2009) was added to the aCSF in
the recording chamber and the recording continued for a
subsequent 10 min. When the CB1 inverse agonist AM251
(N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2, 4-dichlorophenyl)-
4-methyl-1H-pyrazole-3-carboxamide; 1 µM; Tocris; Farkas
et al., 2010, 2013; Lee et al., 2015), the estrogen receptor
antagonist Faslodex/ICI 182,780 (7α, 17β-[9-[(4, 4, 5, 5,
5-Pentafluoropentyl)sulfinyl]nonyl]estra-1, 3, 5(10)-triene-
3, 17-diol; 1 µM; Tocris; Chu et al., 2009; Farkas et al.,
2010) or the ERβ antagonist PHTPP (4-[2-Phenyl-5,7-
bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol;
1 µM; Tocris; Kajta et al., 2013; Saleh et al., 2013) were used, they
were added to the aCSF 10 min before starting the recording.
The diacylglycerol (DAG) lipase inhibitor tetrahydrolipstatin
(THL, N-Formyl-L-leucine (1S)-1-[[(2S, 3S)-3-hexyl-4-oxo-2-
oxetanyl]methyl]dodecyl ester; 10 µM; Tocris; Farkas et al.,
2010, 2013) was added to the intracellular solution in the
pipette to block 2-AG synthesis. To minimize THL spill, the
GnRH cells were approached rapidly (<1 min), and the flow
rate of aCSF was increased from 5–6 to 8–9 ml/min. Just
before release of the positive pressure in the pipette, the flow
rate was restored to 5–6 ml/min to avoid any mechanical
movement of the slice. The pipette solution containing THL
was allowed to equilibrate with the intracellular milieu of
the cell for 15 min before starting recording. For miniature
postsynaptic current (mPSCs) recordings 10 min before start
the spike-mediated transmitter release was blocked by adding
the voltage sensitive Na-channel inhibitor tetrodotoxin (TTX;
646 nM; Tocris) to the aCSF. After 5 min control recording E2
(10 pM), the selective ERα agonist PPT (4,4′,4′′-(4-Propyl-[1H]-
pyrazole-1,3,5-triyl) trisphenol; 10 pM; Tocris), the selective
ERβ agonist DPN (2,3-bis(4-Hydroxyphenyl)-propionitrile;
10 pM; Tocris) or the selective GPR30 receptor agonist G1
((±)-1-[(3aR∗,4S∗,9bS∗)-4-(6-Bromo-1,3-benzodioxol-5-yl)-
3a,4,5,9b-tetrahydro 3H cyclopenta [c] quinolin-8-yl]- ethanone;
10 pM; Tocris) was added to the aCSF respectively, and the
recording continued for a subsequent 10 min. E2, PPT, DPN
and G1 were pipetted onto the slice in a single bolus. In order to
keep comparability, all ER agonists were used at the same 10 pM
concentration.
Statistical Analysis
Each experimental group contained 8–18 recorded cells from
six to nine animals. Responding cells were defined according
to definition of Chu et al. (2009) with modification: cells were
considered as responding ones if any negative change was
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FIGURE 1 | Effect of 17β-estradiol (E2) on the action currents of gonadotropin-releasing hormone (GnRH) neurons in brain slice of metestrous female
mouse. Application of 10 pM E2 resulted in a significant decrease in the frequency of the action currents on GnRH neurons. Individual events during the control
phase (upper inset) and the E2-treated phase (lower inset) present no change. Arrowhead shows the onset of E2 administration.
detected in their frequency. Recordings were stored and analyzed
off-line. Mean firing rate and mPSC frequency were calculated
as number of spikes divided by the length of the respective
period (5 min ‘‘baseline value’’ and 10 min ‘‘agonist period’’,
respectively). Percentage changes resulting from drugs were
calculated by dividing the value to be analyzed before (5min) and
after (the subsequent 10 min) respective agonist administration.
Each neuron served as its own control when drug effects were
evaluated. Event detection was performed using the Clampfit
module of the PClamp 10.4 software (Molecular Devices Co.).
Group data were expressed as mean ± SEM and percentage
change in the frequency of the PSCs due to the application of
various drugs was calculated. Statistical analyses were carried out
using Prism 3.0 (GraphPad Software, Inc., GraphPad). Statistical
significance was analyzed using Kruskal-Wallis test followed by
Dunns post-test for comparison of groups whereas cumulative
probabilities were analyzed with Kolmogorov-Smirnov test and
considered as significant at p< 0.05.
RESULTS
E2 Significantly Decreases the Firing Rate
and Frequency of sPSCs in GnRH Neurons
of Metestrous Female Mice
In order to examine the action of E2 on GnRH neurons of
metestrous female mice, first, loose-patch studies were carried
out. At low physiological concentration (10 pM) E2 decreased
the firing activity of GnRH neurons (Figure 1) in accordance
with the original finding of Chu et al. (2009). Then sPSCs were
recorded to demonstrate the action of E2 in GnRH neurons using
whole-cell patch clamp method. The mean stochastic change in
the frequency of the non-treated ‘‘responding’’ GnRH neurons
was 83.72 ± 3.8% which was used later as control value for the
statistical analysis. Administration of E2 (10 pM) resulted in a
significant decrease in the sPSCs in 9 of 18 of examined GnRH
neurons (49.62 ± 7.6% of the baseline value 1.26 ± 0.4 Hz;
p< 0.05; Figures 2A, 6), whereas the amplitude and decay of the
sPSCs exhibited no change (Figure 6, Table 1) suggesting role
of a presynaptic process. E2 decreased the frequency of sPSCs
within 1–2 min indicating that this phenomenon was due to the
rapid, non-genomic effect of E2. This action was blocked by the
non-selective ER antagonist Faslodex (1 µM; Figures 2B, 6). In
the presence of Faslodex, after E2 application themean frequency
of sPSCs (77.80 ± 5.8% of the baseline values, 2.48 ± 0.8 Hz;
n = 7) was significantly higher (p < 0.05) compared to the
percentage change in the frequency of sPSCs in the case of E2
alone (Figure 6). This result indicated that E2 utilized estrogen
receptor(s) in this rapid effect.
Endocannabinoid 2-AG Signaling is
Involved in E2-Triggered Decrease of sPSC
Frequency
One of our earlier studies showed that endocannabinoid
release from GnRH neuron was able to influence synaptic
transmission to the GnRH neuron itself (Farkas et al., 2010).
Thus, the CB1 inverse agonist AM251 (1 µM) was used
to test the putative role of the retrograde endocannabinoid
signaling mechanism in the mediation of the effect of E2
on GnRH neurons. AM251 pretreatment attenuated the
effect of E2 on the frequency of sPSCs (86.00 ± 4.1% of
the baseline value 1.99 ± 0.5 Hz; n = 6) on GnRH neurons
(Figures 2C, 6), with no change in amplitude (Figure 6,
Table 1), supporting the hypothesis that endocannabinoids
were involved in E2-evoked decrease of sPSC frequency.
There are two main types of endocannabinoids in the
CNS, anandamide and 2-arachidonoylglycerol (2-AG).
Diacylglycerol lipase (DAGL) is the 2-AG synthesizing enzyme,
thus the selective inhibitor of DAGL, THL, was used to
clarify which type of endocannabinoid was involved in the
acute effect of E2 on GnRH neurons. The intracellularly
applied THL (10 µM) diminished the effect of E2 on
the frequency of sPSCs (67.61 ± 5.8% of baseline value
2.18 ± 0.4 Hz; n = 9; Figures 2D, 6), with no change
in amplitude (Figure 6, Table 1) indicating that 2-AG
synthesized by GnRH neurons was involved in the action
of E2.
Effect of E2 is Direct on GnRH Neurons of
Metestrous Female Mice
To examine the putative direct effect of E2 on GnRH neurons,
miniature postsynaptic currents (mPSCs) were recorded in the
presence of TTX (646 nM) to inhibit propagation of action
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FIGURE 2 | Effect of E2 on the spontaneous postsynaptic currents (sPSCs) of GnRH neurons in brain slice of metestrous female mice. (A) E2 in low
concentration (10 pM) decreased the frequency of the sPSCs with no change in the average amplitude of them. One-minute-long periods of the recording before
and after application of E2 are depicted under the recording. Cumulative probability plot presents reduction in the interevent intervals, but not in amplitude.
(B) Pretreatment of the brain slice with the non-selective ER antagonist Faslodex (1 µM, 10 min) inhibited the effect of E2 on the sPSCs. (C) Effect of E2 on the
sPSCs was abolished by the pretreatment with cannabinoid receptor type 1 (CB1) inverse agonist AM251 (1 µM, 10 min). (D) Similar inhibition was observed in case
of intracellularly applied diacylglycerol (DAG) lipase inhibitor THL (10 µM, 20 min). Individual events of sPSCs show no change in waveform properties in the treated
phase (lower insets) as compared to the control phase (upper insets) in all sPSC measurements. Cumulative probability plots in (B–D) graphs present no change in
interevent intervals and amplitudes. Arrowhead shows the onset of drug administration.
potentials during whole-cell patch clamp recording. TTX was
used in all subsequent measurements. The excitatory GABA is
a major mediator of fast synaptic transmission via GABAA-R
on GnRH neurons and the recorded mPSCs observed under
the circumstances used in our experiments were exclusively
GABAergic (Sullivan and Moenter, 2003; Moenter and DeFazio,
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TABLE 1 | Neither the amplitude nor the decay phase of the spontaneous postsynaptic currents (sPSCs) showed significant change after the various
treatments.
Amplitude (control; pA) Amplitude change (% of the control) Decay tau (control; ms) Decay tau change (% of the control)
E2 −37.0 ± 5.0 104.7 ± 3.6 14.9 ± 1.9 129.9 ± 12.4
Faslodex+E2 −33.7 ± 3.9 99.3 ± 4.3 25.4 ± 5.6 148.5 ± 29.5
AM251+E2 −37.4 ± 6.8 112.6 ± 14.1 23.6 ± 4.1 153.9 ± 33.1
THL+E2 −36.3 ± 4.1 101.1 ± 3.6 16.2 ± 1.4 130.3 ± 17.2
The table shows the mean amplitude and decay tau parameters before drug administration and the percentage change in mean amplitudes and decay tau resulting from
the drug application.
2005; Yin et al., 2008; Farkas et al., 2010; Herbison and Moenter,
2011). Administration of E2 (10 pM) caused a significant
decrease in the mean frequency of the GABAergic mPSCs in
GnRH neurons (8 of 12 examined neurons). Frequency of the
mPSCs declined to 50.75± 9.6% (compared to the baseline value
2.29 ± 0.4 Hz; p < 0.05; Figures 3A, 7), while amplitude and
decay of the mPSCs showed no significant alteration (Figure 7,
Table 2).
ERβ is Required for the Rapid Effect of E2
on GnRH Neurons of Metestrous Female
Mice
In order to demonstrate involvement of the ERs in the direct
action of E2 on GnRH neurons, the non-selective ER antagonist
Faslodex (1 µM) was used. The effect of E2 was blocked by
Faslodex (Figure 3B). In the presence of the antagonist, after
E2 administration the mean frequency of mPSCs (84.19 ± 4.0%
of baseline value 0.53 ± 0.1 Hz; n = 6) was significantly higher
(p < 0.05) compared to the value measured with E2 alone
(Figure 7, Table 2). Since the involvement of ER subtypes in
the negative feedback effect of E2 has not been clarified yet,
we used subtype-selective ER agonists to identify the putative
role of ERα and/or ERβ in the mediation of E2 effect on
GnRH neurons. The ERβ agonist DPN (10 pM) significantly
decreased the mean frequency of the mPSCs in GnRH neurons
(60.65 ± 5.1% compared to the baseline value 2.16 ± 0.6 Hz;
n = 8; p < 0.05; Figures 4A, 8). In line with this observation,
the effect of E2 was significantly blocked (73.02 ± 6.1% of
baseline value 0.68 ± 0.1 Hz; n = 7; p < 0.05) by the specific
ERβ antagonist PHTPP (1 µM) administration (Figures 4B, 8).
These results indicate that ERβ is required for the observed
rapid effect of E2 in GnRH neurons. In contrast, the ERα
agonist PPT (10 pM) had no significant effect on the frequency
of mPSCs in GnRH neurons (78.70 ± 6.4% of baseline value
2.32 ± 1.2 Hz; n = 7; p > 0.05; Figures 5A, 8). We also
addressed the putative role of the membrane associated GPR30
in this process. Application of the GPR30 selective agonist G1
(10 pM) had no significant effect on the frequency of the mPSCs
(86.05± 3.5% as compared to the baselined value 0.38± 0.1 Hz;
n = 5; p > 0.05; Figures 5B, 8). The amplitude and decay tau
of the mPSCs did not change upon any of these treatments
(Figure 8, Table 2). These data show that ERα and GPR30 have
no role in mediating the observed rapid effect of the E2 on
GnRH neurons.
Effect of E2 on the mPSCs of GnRH
Neurons is Mediated via Activation of 2-AG
Retrograde Endocannabinoid Signaling
Mechanism
In order to demonstrate that E2 (10 pM) decreases GnRH
neuron mPSC activity via a retrograde endocannabinoid
mechanism AM251 was added to the aCSF. AM251 eliminated
the action of E2 on the GABAergic mPSCs in a significant
manner (86.99 ± 3.5% of baseline value 0.87 ± 0.2 Hz; n = 5;
p < 0.05; Figures 3C, 7). Similar effect was observed when DPN
(10 pM) was used in the presence of AM251 (82.56 ± 2.6%
of baseline value 1.08 ± 0.3 Hz; n = 5; Figures 4C, 8). The
intracellularly applied THL also eliminated the action of E2
on mPSCs (88.39 ± 2.0% of baseline value 0.77 ± 0.2 Hz;
n = 5; p < 0.05; Figures 3D, 7). The amplitude and decay
tau of the mPSCs did not change after these treatments
(Figures 7, 8, Table 2). These results support the idea that the
retrograde endocannabinoid signaling mechanism was involved
in the suppression of GnRH activity when low physiological
concentration of estradiol was used.
DISCUSSION
The present study provides electrophysiological evidence for
the involvement of ERβ and 2-AG signaling in the mediation
of the effect of E2 suppressing fast neurotransmission onto
GnRH neurons in metestrous female mice. Accordingly, (1) E2
significantly decreases the firing rate and frequency of sPSCs and
mPSCs in GnRH neurons; (2) This direct and rapid effect of E2
requires the cooperation of ERβ in GnRH neurons; and (3) The
retrograde endocannabinoid 2-AG signaling is involved in the
E2-triggered decrease of sPSC and mPSC frequency of GnRH
neurons.
E2 Significantly Decreases the Firing Rate
and Frequency of sPSCs and mPSCs in
GnRH Neurons in Metestrous Female Mice
Our results showed that both firing rate and the GABAergic
neurotransmission to GnRH neurons were inhibited by
low physiological dose of E2. These data support earlier
findings showing that E2 at 10 pM concentration is able
to diminish the firing of GnRH neurons (Chu et al., 2009).
In the hypothalamus, estradiol has also been reported to
suppress the neurokinin-B agonist (senktide)-induced firing
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FIGURE 3 | Effect of E2 on the miniature postsynaptic currents (mPSCs) of GnRH neurons in the presence of non-selective estrogen receptor (ER)
antagonist and endocannabinoid receptor/synthesis blockers. (A) E2 decreased the frequency of the mPSCs with no change in the average amplitude of
them. One-minute-long periods of the recording before and after application of E2 are illustrated under the recording. Cumulative probability plot presents reduction
in the interevent intervals, but not in amplitude in the case of the effect of E2 alone on the mPSCs. (B) Pretreatment of the brain slice with the non-selective ER
antagonist Faslodex (1 µM, 10 min) inhibited the action of E2 on the mPSCs. (C) Effect of E2 on the mPSCs was abolished by pretreatment with cannabinoid
receptor type 1 (CB1) inverse agonist AM251 (1 µM, 10 min). (D) Similar inhibition was observed in case of intracellularly applied DAG lipase inhibitor THL (10 µM,
20 min). Arrowhead shows the onset of drug administration. Individual events of mPSC in the control phase (upper insets) and the treated phase (lower insets) show
no change in waveform properties in any measurements (A—D). Cumulative probability plots of treatments in (B–D) graphs show no change in interevent intervals or
amplitudes.
rate in kisspeptin/neurokinin-B/dynorphin (KNDY) neurons
of the arcuate nucleus (Simonian et al., 1999). Regarding
extrahypothalamic actions, spontaneous firing activity of
neurons in the lateral habenula was also inhibited by estrogen
(Kokay et al., 2011). In addition, our data also demonstrated
that frequency of the GABAergic postsynaptic currents
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TABLE 2 | Neither the amplitude nor the decay phase of the miniature postsynaptic currents (mPSCs) showed significant change after the various
treatments.
Amplitude (control; pA) Amplitude change (% of the control) Decay tau (control; ms) Decay tau change (% of the control)
E2 −31.6 ± 3.0 102.4 ± 5.3 9.7 ± 1.7 103.2 ± 18.1
Faslodex+E2 −27.8 ± 2.4 103.0 ± 2.2 7.1 ± 0.9 95.9 ± 20.1
AM251+E2 −24.7 ± 2.2 101.3 ± 3.5 8.6 ± 2.6 103.3 ± 28.5
THL+E2 −30.0 ± 4.3 93.8 ± 3.4 5.7 ± 1.2 104.7 ± 29.2
DPN −36.6 ± 6.7 102.9 ± 5.1 14.1 ± 2.2 114.5 ± 11.3
PHTPP+E2 −26.6 ± 3.0 100.1 ± 4.0 9.5 ± 1.2 102.4 ± 22.4
AM251+DPN −32.7 ± 10.6 97.1 ± 6.0 6.6 ± 1.3 128.4 ± 26.6
PPT −28.7 ± 3.1 98.7 ± 6.7 12.9 ± 1.6 108.2 ± 15.8
G1 −33.0 ± 2.6 98.8 ± 2.2 6.0 ± 0.7 116.0 ± 19.3
The table shows the mean amplitude and decay tau before drug administration and the percentage change in these parameters resulting from the drug administrations.
FIGURE 4 | The effect of ERβ activation on the mPSCs in GnRH neurons of the metestrous female mice: outcome of ERβ antagonist, agonist and CB1
blocker. (A) The subtype-selective ERβ agonist DPN (10 pM, 10 min) significantly decreased the frequency of mPSCs. One-minute long periods of the recording
before and after application of the agonist are illustrated under the recording. Cumulative probability plot presents reduction of the interevent intervals, but not in
amplitude. (B) Pretreatment of the brain slice with the selective ERβ receptor antagonist PHTPP (1 µM, 10 min) inhibited the effect of E2 on mPSCs. (C) ERβ agonist
DPN had no significant effect on the frequency of mPSCs in the presence of AM251 (1 µM, 10 min). Arrowhead shows the onset of drug administration. Individual
events of mPSC show no change in waveform properties of the treated phase (lower insets) as compared to the control phase (upper insets) in any of the mPSC
measurements. Cumulative probability plots show no change in interevent intervals and amplitudes in (B,C) graphs.
was decreased upon E2 treatment in GnRH neurons of
metestrous female mice. Not surprisingly, neurons of other
brain regions, such as hippocampus, exhibit decreased PSC
frequency upon estradiol treatment (Huang and Woolley,
2012; Tabatadze et al., 2015). Kisspeptin neurons of the arcuate
nucleus were also shown to respond to E2 administration
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FIGURE 5 | The selective ERα agonist and G protein-coupled estrogen receptor (GPR30) agonist exert no effects on the mPSCs in GnRH neurons of
the metestrous female mice. (A) The selective ERα agonist PPT (10 pM, 10 min) was unable to modify the frequency of mPSCs in the recorded GnRH neurons.
(B) Similarly, the GPR30 receptor agonist G1 (10 pM; 10 min) did not modify the frequency of the mPSCs. Arrowhead shows the onset of drug administration.
Individual events of mPSC show no change in waveform properties of the treated phase (lower insets) compared to the control phase (upper insets) in each mPSC
measurements. Cumulative probability plots of the treatments show no change in interevent intervals or amplitudes.
FIGURE 6 | Bar graph summarizing the percentage changes in the frequency and the amplitude of the sPSCs resulting from E2 treatment in the
presence of Faslodex, AM251 and THL. E2 significantly decreased the frequency of sPSCs. Inhibition of its effect could be achieved with antagonizing the ERs,
CB1 receptors or blocking the intracellular 2-AG endocannabinoid synthesis. The amplitude of the mPSCs did not change in any of the treatments. ∗p < 0.05 as
compared to the control; ∗∗p < 0.05 as compared to the change evoked by E2 treatment.
with a reduced mPSC frequency (DeFazio et al., 2014). Our
results, therefore, is in a good agreement with the earlier
results, revealing positive correlation between firing rate
and frequency of postsynaptic currents in GnRH neurons
(Chu and Moenter, 2005; Christian and Moenter, 2007; Farkas
et al., 2013).
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FIGURE 7 | Bar graph summarizing the percentage changes in the frequency and the amplitude of the mPSCs resulting from E2 treatment in the
presence of Faslodex, AM251 and THL. E2 significantly decreased the frequency of mPSCs. Inhibition of this effect could be achieved with antagonizing the ERs
by Faslodex. Effect of E2 was eliminated by the pretreatment with CB1 inverse agonist AM251 or the intracellularly applied 2-AG endocannabinoid synthesis blocker
THL. The amplitude of the mPSCs did not change in any of the treatments. ∗p < 0.05 as compared to the control; ∗∗p < 0.05 as compared to the change evoked by
E2 treatment.
FIGURE 8 | Bar graph summarizing the percentage changes in the frequency and the amplitude of the mPSCs resulting from selective ER agonists
and various antagonists. The E2 and the selective ERβ agonist DPN significantly decreased the frequency of mPSCs. Effect of DPN was eliminated by the
pretreatment with CB1 inverse agonist AM251. Effect of E2 could be inhibited by antagonizing selectively the ERβ by PHTPP. The selective ERα agonist PPT and the
GPR30 receptor agonist G1 had no significant effect on the frequency of mPSCs. The amplitude of the mPSCs presented no change in any of the treatments.
∗p < 0.05 compare to the control; ∗∗p < 0.05 as compared to the change caused by E2 treatment.
The Execution of Direct, Rapid Effect of E2
Requires ERβ in GnRH Neurons
Till the late 1990’s, the general consensus has been that E2
modulates GnRH neurons via estrogen-sensing interneurons
located in hypothalamic and different extrahypothalamic loci,
because earlier studies using autoradiography combined with
immunocytochemistry showed that GnRH neurons did not
express ER (Shivers et al., 1983), whereas certain neuron sets
innervating GnRH neurons contained nuclear ERα (Herbison,
1998; Simonian et al., 1999; Smith et al., 2005; Franceschini
et al., 2006). The discovery of ERβ (Kuiper et al., 1996) lead
to the finding that ERβ was expressed in GnRH neurons in
rodents (Hrabovszky et al., 2000, 2001; Herbison and Pape,
2001; Kalló et al., 2001) and humans (Hrabovszky et al.,
2007). Moreover, a broad range of experiments demonstrated
that E2 acted directly on GnRH neurons (Abrahám et al.,
2003; Petersen et al., 2003; Temple et al., 2004; Abe and
Terasawa, 2005; Abe et al., 2008; Chu et al., 2009). In this
work, our laboratory extended these studies by examining
the direct effect of E2 in GnRH neurons of metestrous
female mice. Administration of low physiological concentration
(10 pM) of E2 resulted in a significant decrease in the sPSC
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FIGURE 9 | Schematic illustration of the interaction between E2 and endocannabinoid signaling in GnRH neuron of the metestrous female mice.
Binding of E2 to ERβ activates synthesis and release of 2-AG in the GnRH neuron. The released endocannabinoid 2-AG then binds to CB1 expressed in the
presynaptic terminal of GABAergic afferents and causes suppression of GABA release into the synaptic cleft. This effect of E2 was blocked when the non-selective
ER antagonist (Faslodex) or the selective ERβ receptor antagonist (PHTPP) was administered. The signaling was also inhibited when the CB1 inverse agonist
(AM251) or the DAG lipase inhibitor (THL) was applied. E2, 17β-estradiol; ERβ, estrogen receptor beta; DPN, subtype selective ERβ agonist; DAG, diacylglycerol;
DGL, DAG-lipase; CB1, cannabinoid receptor type-1; AM251, CB1 inverse agonist; Faslodex, non-selective estrogen receptor antagonist; PHTPP, subtype selective
ERβ antagonist; 2-AG, 2-arachidonoylglycerol; THL, tetrahydrolipstatin (DAG-lipase inhibitor); PIP2, phosphatidylinositol 4,5-bisphosphate; IP3, inositol
1,4,5-trisphosphate; PLC, phospholipase-C; GABAA-R, GABAA receptor; [Ca2+I ], intracellular free calcium; VGCC, voltage-gated calcium channel. Dashed arrow
denote putative action.
frequency in GnRH neurons within 1–2 min. This action
was inhibited by administration of the non-selective estrogen
receptor antagonist, Faslodex, indicating the involvement of
estrogen receptor(s) in this rapid effect. Furthermore, application
of E2 resulted in a significant decrease in the mean frequency
of the mPSCs in GnRH neurons indicating that the observed
effect of E2 was direct on GnRH neurons. When the 2-
AG endocannabinoid synthesis blocker THL was administered
intracellularly, it eliminated the effect of E2 on mPSCs
confirming further that the effect of E2 on GnRH neurons
was direct. In addition, this action of E2 was rapid, in the
range of a few minutes, suggesting activation of intracellular
signaling pathways via membrane-associated receptors, such
as ERα, ERβ, and the GPR30 (Abe et al., 2008; Kelly and
Rønnekleiv, 2012; Radovick et al., 2012; Kwakowsky et al.,
2014).
In order to identify the exact subtype of the ER mediating
this rapid E2 action in GnRH neurons, we examined the effect
of various subtype-selective ER agonists. The ERβ agonist DPN
significantly decreased the mean frequency of the mPSCs in
GnRH neurons. Moreover, the effect of E2 was significantly
blocked by the ERβ specific antagonist PHTPP. In contrast,
neither the ERα agonist PPT nor the GPR30 selective agonist
G1 had significant effect. These findings indicate that ERβ
is required exclusively for the observed rapid effects of E2
in GnRH neurons. In line with this observation, in vivo
studies in ovariectomized mice showed that GnRH neurons
responded to estrogen in a rapid and direct manner through
an ERβ-dependent mechanism (Abrahám et al., 2003). Our
present experiments provided further evidence about the
pivotal role of ERβ in the mediation of the rapid effect
of E2 in GnRH neurons in acute slice preparation from
metestrous female mice during the negative estrogen feedback
period.
Retrograde 2-AG Signaling is Involved in
the E2-Triggered Decrease of sPSC and
mPSC Frequency in GnRH Neurons
The GABA neurotransmission has been considered as one of the
main regulatory signaling to GnRH neurons. Series of studies
proved that GABA acts as an excitatory neurotransmitter on
postsynaptic GABAA-R channels of adult GnRH neurons of
rodents (DeFazio et al., 2002; Moenter and DeFazio, 2005;
Yin et al., 2008; Watanabe et al., 2009, 2014; Herbison and
Moenter, 2011; Taylor-Burds et al., 2015). Furthermore, several
experiments demonstrated that the frequency of the GABAergic
mPSCs was in a positive correlation with the firing activity
of these neurons (Chu and Moenter, 2005; Christian and
Moenter, 2007; Chen and Moenter, 2009; Farkas et al., 2010).
A previous study from our laboratory demonstrated that the
2-AG release from GnRH neurons resulted in a simultaneous
reduction of the firing rate and GABAergic neurotransmission
to GnRH neurons via GABAA-R. GnRH neurons present a
tonic 2-AG production because both AM251 and THL could
influence the GABAergic input of these cells (Farkas et al., 2010).
Therefore, the E2-triggered decline in the firing rate and the
frequency of the mPSCs may suggest the putative involvement
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of the retrograde endocannabinoid signaling machinery in the
manifestation of the suppressing effect of E2 in the metestrus
stage. It is in line with a previous report demonstrating that
release of endocannabinoids indeed regulated the function of
GnRH neurons (Glanowska and Moenter, 2011). Thus, our
data that AM251 and the intracellularly applied THL inhibited
the effect of the low physiological dose of E2 in the negative
feedback period suggest the involvement of retrograde 2-AG
signaling mechanism in the achievement of E2-evoked changes
observed in the PSCs of the GnRHneuron. The endocannabinoid
system has also been described as a downstream element of E2
pathway in adult female rat hippocampus where a principal role
of retrograde endocannabinoid signaling in the E2-dependent
suppression of inhibitory GABAergic neurotransmission to CA1
pyramidal neurons was elucidated (Huang and Woolley, 2012).
Our intracellular THL administration proved that the E2-
evoked 2-AG synthesis took place in GnRH neurons. In line
with this, a previous study showed that immortalized GnRH
neurons synthesize 2-AG (Gammon et al., 2005) and patch
clamp experiments on GnRH neurons in acute brain slices
also supported this finding (Farkas et al., 2010; Glanowska
and Moenter, 2011). Endocannabinoids are synthesized and
released from postsynaptic GnRH neurons upon E2 activation,
thereafter, they act in a retrograde manner on CB1 receptors
expressed in presynaptic axon terminals innervating GnRH
neurons, similarly to other, endocannabinoid-regulated systems
(Sugiura and Waku, 2000; Piomelli, 2003; Kano et al., 2009;
Ohno-Shosaku and Kano, 2014).
The proposed model of E2 action on the GnRH neuron is
illustrated in Figure 9.
To sum up, this study suggests that E2 binds to ERβ
and triggers the synthesis and release of 2-AG from GnRH
neurons. Then, 2-AG binds to CB1 located in the presynaptic
terminals of GABAergic afferents, which eventually causes
the suppression of GABA release into the synaptic cleft
and in turn, the repression of electric activity of GnRH
neurons. The elucidation of the putative participation of
the ERβ-2-AG signaling mechanism in GnRH neurons
of humans raises a further challenge in understanding
the pathophysiology of central, hypothalamic regulatory
mechanisms of the GnRH neuronal network orchestrating
reproduction.
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